Paid Clinical Trials Portland

Discover 167 paid clinical trials in Portland, Maine. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 167

Upadacitinib vs. AdalimumabStudy to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Recruiting

PHASE3

Sponsor:

AbbVie

Location:

Portland ME, Boston MA, Lebanon NH, Trois-rivieresshow 77 more

Code:

NCT05814627

Conditions

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Upadacitinib

Adalimumab

Upadacitinib Matching Placebo

Adalimumab Matching Placebo

Neratinib & PalbociclibTesting the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Scarborough ME, Brewer ME, Jersey City NJ, Syracuse NYshow 111 more

Code:

NCT06126276

Conditions

Malignant Female Reproductive System Neoplasm

Malignant Solid Neoplasm

Recurrent Malignant Female Reproductive System Neoplasm

Recurrent Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Echocardiography Test

Magnetic Resonance Imaging

SelinexorSelinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

Recruiting

PHASE3

Sponsor:

Karyopharm Therapeutics Inc

Location:

Scarborough ME, Boston MA, Albany NY, Montrealshow 71 more

Code:

NCT05611931

Conditions

Endometrial Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Selinexor

Matching Placebo for selinexor

TriptorelinTriptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

Recruiting

PHASE3

Sponsor:

Children's Oncology Group

Location:

Scarborough ME, Providence RI, Albany NY, Stony Brook NYshow 61 more

Code:

NCT06513962

Conditions

Hematopoietic and Lymphatic System Neoplasm

Malignant Solid Neoplasm

Eligibility Criteria

Sex: Female

Age: 0 - 39

Healthy Volunteers: Not accepted

Interventions

Best Practice

Biospecimen Collection

Electronic Health Record Review

Survey Administration

Triptorelin Pamoate

SaruparibSaruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Scarborough ME, Providence RI, Norwich CT, Albany NYshow 115 more

Code:

NCT06120491

Conditions

Metastatic Castration-Sensitive Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Saruparib

Placebo

Abiraterone Acetate

Darolutamide

Enzalutamide

Paclitaxel & IpatasertibStudy of Chemotherapy Plus Ipatasertib for People With Solid Tumors With PTEN/AKT Mutations, A ComboMATCH Treatment Trial

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Scarborough ME, Augusta ME, Boston MA, Brewer MEshow 165 more

Code:

NCT05554380

Conditions

Locally Advanced Malignant Solid Neoplasm

Metastatic Malignant Solid Neoplasm

Unresectable Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Ipatasertib

Magnetic Resonance Imaging

ColonoscopyFive or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Recruiting

Sponsor:

NRG Oncology

Location:

Scarborough ME, Jamaica Plain MA, Providence RI, North Haven CTshow 297 more

Code:

NCT05080673

Conditions

Adenocarcinoma of the Colon

Adenocarcinoma of the Rectum

Eligibility Criteria

Sex: All

Age: 50 - 70

Healthy Volunteers: Not accepted

Interventions

5-year and 10 Year Surveillance Colonoscopy after Qualifying Colonoscopy

Cisplatin & RadiationComparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

Recruiting

PHASE2

PHASE3

Sponsor:

NRG Oncology

Location:

Portland ME, South Portland ME, Scarborough ME, Biddeford MEshow 259 more

Code:

NCT05050162

Conditions

Advanced Head and Neck Squamous Cell Carcinoma

Advanced Hypopharyngeal Squamous Cell Carcinoma

Advanced Laryngeal Squamous Cell Carcinoma

Advanced Oropharyngeal Squamous Cell Carcinoma

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cisplatin

Computed Tomography

Magnetic Resonance Imaging

Positron Emission Tomography

Quality-of-Life Assessment

MILDMILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

Recruiting

Sponsor:

Vertos Medical, Inc.

Location:

York ME, Dover NH, Portsmouth NH, Stratham NHshow 1096 more

Code:

NCT03072927

Conditions

Lumbar Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MILD

Interspinous Process Decompression

Epcoritamab & Rituximab, LenalidomideStudy of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma

Recruiting

PHASE3

Sponsor:

Genmab

Location:

Scarborough ME, Troy NY, Albany NY, Westbury NYshow 33 more

Code:

NCT06191744

Conditions

Follicular Lymphoma (FL)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Epcoritamab

Prednisone

Rituximab

Lenalidomide

Doxorubicin